Chemoinformaics analysis of ALLYL ALPHA-IONONE
| Molecular Weight | 232.367 | nRot | 5 |
| Heavy Atom Molecular Weight | 208.175 | nRig | 9 |
| Exact Molecular Weight | 232.183 | nRing | 1 |
| Solubility: LogS | -5.203 | nHRing | 0 |
| Solubility: LogP | 4.791 | No. of Aliphatic Rings | 1 |
| Acid Count | 0 | No. of Aromatic Rings | 0 |
| Base Count | 0 | No. of Aliphatic Carbocycles Rings | 1 |
| Atoms Count | 41 | No. of Aliphatic Hetero Cycles | 0 |
| No. of Heavy Atom | 17 | No. of Aromatic Carbocycles | 0 |
| nHetero | 1 | No. of Aromatic Hetero Cycles | 0 |
| nBridge Head | 0 | No. Saturated Carbocycles | 0 |
| No. of Hydrogen atom | 24 | No. of Saturated Hetero Cycles | 0 |
| No. of Carbon atom | 16 | No. of Saturated Rings | 0 |
| No. of Nitrogen atom | 0 | No. of Arom Atom | 0 |
| No. of Oxygen atom | 1 | No. of Arom Bond | 0 |
| nHA | 1 | APOL | 43.525 |
| nHD | 0 | BPOL | 24.945 |
| QED | 0.5 |
| Synth | 2.901 |
| Natural Product Likeliness | 2.055 |
| NR-PPAR-gamma | 0.784 |
| Lipinski | Accepted |
| Pfizer | Rejected |
| GSK | Rejected |
| Golden Triangle | Accepted |
| Pgp-inh | 0.992 |
| Pgp-sub | 0.001 |
| HIA | 0.004 |
| CACO-2 | -4.599 |
| MDCK | 0.0000235 |
| BBB | 0.084 |
| PPB | 0.950952 |
| VDSS | 1.629 |
| FU | 0.0199512 |
| CYP1A2-inh | 0.423 |
| CYP1A2-sub | 0.896 |
| CYP2c19-inh | 0.532 |
| CYP2c19-sub | 0.913 |
| CYP2c9-inh | 0.226 |
| CYP2c9-sub | 0.776 |
| CYP2d6-inh | 0.497 |
| CYP2d6-sub | 0.92 |
| CYP3a4-inh | 0.433 |
| CYP3a4-sub | 0.504 |
| CL | 2.432 |
| T12 | 0.499 |
| hERG | 0.029 |
| Ames | 0.041 |
| ROA | 0.523 |
| SkinSen | 0.9 |
| Carcinogencity | 0.885 |
| EI | 0.832 |
| Respiratory | 0.96 |
| NR-Aromatase | 0.259 |
| Antiviral | Yes |
| Prediction | 0.864543 |